Cardio-hepatic risk assessment by CMR imaging in liver transplant candidates-Reference-Cited by-同舟云学术

Cardio-hepatic risk assessment by CMR imaging in liver transplant candidates

Published:2018-04-11 Issue:5 Volume:32 Page:e13229
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Reddy Sahadev T.¹^ORCID,Thai Ngoc L.²,Oliva Jose³,Tom Kusum B.²,Dishart Michael K.⁴,Doyle Mark¹,Yamrozik June A.¹,Williams Ronald B.¹,Shah Moneal¹,Wani Adil⁵,Singh Anil⁶,Maheswary Rishi⁷,Biederman Robert W.W.¹

Affiliation:

1. Cardiovascular Magnetic Resonance Imaging; Cardiovascular Institute; Allegheny General Hospital; Pittsburgh PA USA

2. Surgery; Allegheny General Hospital; Pittsburgh PA USA

3. Gastroenterology; Allegheny General Hospital; Pittsburgh PA USA

4. Anesthesiology; Allegheny General Hospital; Pittsburgh PA USA

5. Department of Medicine; Allegheny General Hospital; Pittsburgh PA USA

6. Pulmonary Medicine; Allegheny General Hospital; Pittsburgh PA USA

7. Department of Radiology; Allegheny General Hospital; Pittsburgh PA USA

Publisher

Wiley

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ctr.13229/fullpdf

Reference37 articles.

1. Is there disparity between risk and incidence of cardiovascular disease after liver transplant?;Neal;Transplantation,2002

2. The changing of patients presenting for liver transplantation;Xia;Curr Opin Organ Transplant,2008

3. Cirrhotic cardiomyopathy and liver transplantation;Meyers;Liver Transpl,2000

4. Coronary artery disease and liver transplantation: the state of the art;Plotkin;Liver Transpl,2000

5. Frequency and significance of acute heart failure following liver transplantation;Eimer;Am J Cardiol,2008

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

2. EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD);Obesity Facts;2024

3. Evaluation of recipients with significant comorbidity – Patients with cardiovascular disease;Journal of Hepatology;2023-06

4. Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association;Circulation;2022-11-22

5. Pre-transplant Cardiovascular Risk Assessment and Modification;Current Treatment Options in Gastroenterology;2022-04-12